InvestorsHub Logo
Followers 246
Posts 636
Boards Moderated 1
Alias Born 04/20/2007

Re: None

Tuesday, 08/19/2014 7:29:24 AM

Tuesday, August 19, 2014 7:29:24 AM

Post# of 97239
$SYN catalyst near term $1.83

Took a starter position yesterday. Company has two near term catalyst that might move the stock

Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC Sept 7th oral presentation
http://finance.yahoo.com/news/synthetic-biologics-announces-breaking-poster-105600116.html

Sept 10-13 Joint ACTRIMS-ECTRIMS conference http://www.msboston2014.org

Q2 transcript
http://seekingalpha.com/article/2423855-synthetic-biologics-syn-ceo-jeff-riley-on-q2-2014-results-earnings-call-transcript

"In addition to the positive results reported last quarter from the investigator initiated phase II study of Trimesta we recently announced that lead investigator Dr. Rhonda Voskuhl of UCLA plans to discuss further findings from this study at the Joint ACTRIMS-ECTRIMS Meeting in September."

"We look forward to updating shareholders on Dr. Voskuhl’s continued analysis as we continue to explore to many different avenues for extracting maximum value for this asset to include finding a potential MS strategic partner."

"A lot of the additional data Dr. Voskuhl will present results from previous and ongoing analysis of patient MRI brain scans. These analysis will continue over the next few months and as you might imagine, as this new outcome data has become available, we've included a new patent filings in ways that we will believe will not only significantly expand and enhance protected features of this increasingly valuable asset, but also substantially lengthen it's market exclusivity."

Key financial stats
http://finance.yahoo.com/q/ks?s=SYN+Key+Statistics

-BioHunter

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.